Avalyn Pharma, Inc. (AVLN)

26.04 -1.21 (-4.44%) USD  |  NASDAQ  |  Oct 23, 16:00
26.04 0.00 (0.00%) After-Hours: 20:00
More

Avalyn Pharma EPS Diluted (Quarterly) : -0.6527 for June 30, 2026

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2025. Start Trial.
Date Value
June 30, 2026 -0.6527
March 31, 2026 -0.6061
Date Value
June 30, 2025 -0.4554
March 31, 2025 -0.3948

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Filana Therapeutics, Inc. -0.1781
CorMedix, Inc. 0.281
Eloxx Pharmaceuticals, Inc. -0.6631
Breakthrough Chemistry, Inc. -0.1113
BioStem Technologies, Inc. -0.5178

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -28.94M
Total Expenses (Quarterly) 28.94M
Enterprise Value 872.76M
Earnings Yield -8.10%
Normalized Earnings Yield -8.099